Indian Pharma industry moving towards formulations

Indian Pharma industry is slowing moving up the value chain. Earlier it used to manufacture active pharmaceutical ingredient at low cost compared to world. Now with competition from China, which provides API at 15-20% low cost, it makes sense to shift focus elsewhere. Many top companies like Lupin, Novartis, Ranbaxy have less revenue stream from API than from formulations. There could also be the reason that formulation business has grown faster than APIs for some companies. API is low scale commodity with low margin. Moreover, with a large number of patent expiries in developed markets like the US and Europe, Indian companies, with skills to develop and manufacture low-cost generic drugs, see a much more lucrative opportunity there than utilising their capacities for manufacturing APIs.
Read More

  • No Image
    Visa Drugs Pharmaceuticals Pvt Ltd

    Visa Drugs and Pharmaceuticals Pvt Ltd was incorporated on 7th July, 2008 by Sri Aditya Balasaria, (MBA UK) and Shri Madhusudan Balasaria. The registered office is located at Ko

  • No Image
    Vista Pharmaceuticals Ltd

    Vista Pharmaceuticals offers over the counter & prescription generic drug products consisting of tablets, capsules and liquids covering various therapeutic categories. Vista Pha

  • No Image
    Vitrag Chemicals Pvt Ltd

    Suvidhi Industries is a bulk supplier of Caustic Soda Flakes, Caustic Soda Lye, Soda Ash, Hydrochloric Acid, Acetic Acid, Hydrogen Peroxide, Sodium Hypo Chlorite & many other ch

  • No Image
    Vivek Pharmachem India Ltd

    Vivek Pharmachem India Ltd was incorporated in 1975 by Mr. Kuldeep Gupta as a partnership concern named ?Vivek Pharmaceuticals?. Later on, it was converted into private limited